K K Ferguson1, T F McElrath2, D E Cantonwine2, B Mukherjee3, J D Meeker4. 1. Department of Environmental Health Sciences, University of Michigan School of Public Health, 1415 Washington Heights, Ann Arbor, MI 48109-2029, USA. 2. Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. 3. Department of Biostatistics, University of Michigan School of Public Health, 1415 Washington Heights, Ann Arbor, MI 48109-2029, USA. 4. Department of Environmental Health Sciences, University of Michigan School of Public Health, 1415 Washington Heights, Ann Arbor, MI 48109-2029, USA. Electronic address: meekerj@umich.edu.
Abstract
INTRODUCTION: Phthalates and bisphenol-a (BPA) are endocrine disrupting compounds with widespread exposure that have been linked to adverse birth outcomes and developmental effects. We hypothesized that these associations may be mediated in part through altered placental development and function consequent to exposure. To investigate this question, we examined associations between plasma biomarkers of angiogenesis and urinary biomarkers of exposure to phthalates and bisphenol-a (BPA) measured at repeated time points across pregnancy. METHODS: We utilized a nested case-control population of 130 mothers who delivered preterm and 352 who delivered term from a prospective birth cohort. Placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) were measured in plasma samples collected from up to four visits during pregnancy (median 10, 18, 26, and 35 weeks). Phthalate metabolites and BPA were measured in urine samples collected at the same visits as indices of exposure. RESULTS: In linear mixed effects models adjusted for urine dilution and gestational age at sample collection, oxidized di-2-ethylhexyl phthalate (DEHP) metabolites were associated with decreases in PlGF as well as increases in the sFlt-1 to PlGF ratio. These results were slightly attenuated in fully adjusted models. Other phthalate metabolites did not show consistent relationships with either sFlt-1 or PlGF. BPA, however, was associated with increased sFlt-1 as well as the sFlt-1 to PlGF ratio in both crude and adjusted models. DISCUSSION: We observed associations between urinary DEHP metabolites and BPA and biomarkers of angiogenesis during pregnancy that may be indicative of disrupted placental development and/or function during gestation.
INTRODUCTION:Phthalates and bisphenol-a (BPA) are endocrine disrupting compounds with widespread exposure that have been linked to adverse birth outcomes and developmental effects. We hypothesized that these associations may be mediated in part through altered placental development and function consequent to exposure. To investigate this question, we examined associations between plasma biomarkers of angiogenesis and urinary biomarkers of exposure to phthalates and bisphenol-a (BPA) measured at repeated time points across pregnancy. METHODS: We utilized a nested case-control population of 130 mothers who delivered preterm and 352 who delivered term from a prospective birth cohort. Placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) were measured in plasma samples collected from up to four visits during pregnancy (median 10, 18, 26, and 35 weeks). Phthalate metabolites and BPA were measured in urine samples collected at the same visits as indices of exposure. RESULTS: In linear mixed effects models adjusted for urine dilution and gestational age at sample collection, oxidized di-2-ethylhexyl phthalate (DEHP) metabolites were associated with decreases in PlGF as well as increases in the sFlt-1 to PlGF ratio. These results were slightly attenuated in fully adjusted models. Other phthalate metabolites did not show consistent relationships with either sFlt-1 or PlGF. BPA, however, was associated with increased sFlt-1 as well as the sFlt-1 to PlGF ratio in both crude and adjusted models. DISCUSSION: We observed associations between urinary DEHP metabolites and BPA and biomarkers of angiogenesis during pregnancy that may be indicative of disrupted placental development and/or function during gestation.
Authors: Anna M Vetrano; Debra L Laskin; Faith Archer; Kirin Syed; Joshua P Gray; Jeffrey D Laskin; Nkiru Nwebube; Barry Weinberger Journal: Pediatr Res Date: 2010-08 Impact factor: 3.756
Authors: Paul C Welch; Kofi S Amankwah; Patience Miller; Mary E McAsey; Donald S Torry Journal: Am J Obstet Gynecol Date: 2006-04-25 Impact factor: 8.661
Authors: Laura N Vandenberg; Maricel V Maffini; Carlos Sonnenschein; Beverly S Rubin; Ana M Soto Journal: Endocr Rev Date: 2008-12-12 Impact factor: 19.871
Authors: Stephanie M Engel; Chenbo Zhu; Gertrud S Berkowitz; Antonia M Calafat; Manori J Silva; Amir Miodovnik; Mary S Wolff Journal: Neurotoxicology Date: 2009-04-16 Impact factor: 4.294
Authors: Mary S Wolff; Stephanie M Engel; Gertrud S Berkowitz; Xiaoyun Ye; Manori J Silva; Chenbo Zhu; James Wetmur; Antonia M Calafat Journal: Environ Health Perspect Date: 2008-08 Impact factor: 9.031
Authors: Giuseppe Latini; Claudio De Felice; Giuseppe Presta; Antonio Del Vecchio; Irma Paris; Fabrizio Ruggieri; Pietro Mazzeo Journal: Environ Health Perspect Date: 2003-11 Impact factor: 9.031
Authors: Elise M Philips; Leonardo Trasande; Linda G Kahn; Romy Gaillard; Eric A P Steegers; Vincent W V Jaddoe Journal: Hum Reprod Date: 2019-02-01 Impact factor: 6.918
Authors: Emma M Rosen; Mg Isabel Muñoz; Thomas McElrath; David E Cantonwine; Kelly K Ferguson Journal: J Toxicol Environ Health B Crit Rev Date: 2018-12-24 Impact factor: 6.393
Authors: Andrea Bellavia; Russ Hauser; Ellen W Seely; John D Meeker; Kelly K Ferguson; Thomas F McElrath; Tamarra James-Todd Journal: Int J Hyg Environ Health Date: 2017-09-12 Impact factor: 5.840
Authors: Kelly K Ferguson; Thomas F McElrath; Gerry G Pace; David Weller; Lixia Zeng; Subramaniam Pennathur; David E Cantonwine; John D Meeker Journal: Environ Sci Technol Date: 2017-03-29 Impact factor: 9.028